“As a Principal Investigator, I have the privilege of partnering with the study volunteers to potentially make a real difference in the management of their illness, and therefore their lives, by advancing our understanding of the most effective treatments. I wholeheartedly believe that appropriate subject selection and quality data are an integral part of developing cutting edge interventions. By developing new treatments, we can offer hope to those who find themselves challenged by these diagnoses. I am thrilled to be working with my colleagues here at Artemis who share my passion for conducting first-class clinical trials.”

Dr. Patrick received her Bachelor’s degree in Psychology and Social Behavior from UC Irvine and then attended Palo Alto University for her Ph.D., where she focused on the study of women with PTSD. Dr. Patrick then went on to complete her fellowship at Alliant International University where she worked as adjunct faculty and presented papers focusing on the Rorschach scoring system at the national conference for the Society of Personality Assessment. After licensure, she worked as a centralized rater in Phase III psychiatric clinical trials for approximately 6 years. Since 2015, she has worked as an Investigator in Phase I and II clinical CNS pharmaceutical trials. As a Principal Investigator, her main areas of research expertise include, Mood Disorders, Schizophrenia, and Alzheimer’s Disease. Dr. Patrick joined the Artemis Research team in 2018.